Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency (MOHC)
Migraine, Hemicrania
About this trial
This is an interventional treatment trial for Migraine, Hemicrania
Eligibility Criteria
Inclusion Criteria:
age >18 yrs diagnosis of MOH and CM (1) written informed consent
Exclusion Criteria:
co-existent severe medical or psychiatric illnesses, documented by specific previous diagnoses seizures use of opioids
Sites / Locations
- Fondazione IRCCS Istituto Neurologico C. Besta, Neuroalgology UnitRecruiting
Arms of the Study
Arm 1
Other
Symptomatic drugs - bridge theray - mindfu
abrupt withdrawal of overuse symptomatic drugs, with possibility to use indomethacin suppository 50-100 mg or an oral triptan, on maximum 3 days/10 days, only in case of very severe headache- and to use metoclopramide i.m. injection in case of vomiting; oral administration of a bridge therapy to reduce the withdrawal symptoms and rebound headache (prednisone 25 mg , 2 tablets after breakfast for 5 days, one tablet for 3 days, half tablet for 2 days ; bromazepam 1.5 mg, 1 tablet after breakfast, lunch and dinner for every day; pantoprazole 40 mg, 1 tablet after dinner every day); mindfulness practice daily with standard sessions by smartphone 6 minutes per day.